HCV MULTIPLE EPITOPE FUSION ANTIGENS WITH MODIFIED PROTEOLYTIC CLEAVAGE SITES AND USES THEREOF

摘要

Modified HCV multiple epitope fusion antigens (MEFAs) are described. The proteins include modified sequences such that proteolytic cleavage of the MEFAs by HCV NS3 protease is inhibited. HCV immunoassays including the modified MEFAs are also described.